Prestige Consumer Healthcare (FRA:PBV) Institutional Ownership: 98.30% (As of Aug. 21, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:PBV Prestige Consumer Healthcare Inc FRA:PBV
68 GF Score
Price €42.20
GF Value €58.90
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is Prestige Consumer Healthcare Institutional Ownership?

Prestige Consumer Healthcare FRA:PBV -3.65% 68 Institutional Ownership is 98.30% as of Aug. 21, 2026. GuruFocus rates FRA:PBV with a GF Score™ of 68/100 and a GF Value™ of €58.90 (Modestly Undervalued). The stock has 2 warning signs investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Prestige Consumer Healthcare's institutional ownership is 98.30%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Prestige Consumer Healthcare's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Prestige Consumer Healthcare's Float Percentage Of Total Shares Outstanding is 82.89%.

Prestige Consumer Healthcare Institutional Ownership Historical Data

* Premium members only.

The historical data trend for Prestige Consumer Healthcare's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Prestige Consumer Healthcare Institutional Ownership Chart

Prestige Consumer Healthcare Historical Data

The historical data trend for Prestige Consumer Healthcare can be seen below:

2025-09-30 2025-10-31 2025-11-30 2025-12-31 2026-01-31 2026-02-28 2026-03-31 2026-04-30 2026-05-31 2026-06-30
Institutional Ownership 76.72 75.16 75.20 77.44 77.01 77.97 79.42 79.45 82.45 98.30
FRA:PBV
68GF Score
Prestige Consumer Healthcare Inc FRA:PBV
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Prestige Consumer Healthcare Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 98.30% mean?
Prestige Consumer Healthcare (FRA:PBV) has a Institutional Ownership of 98.30% as of Aug. 21, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Prestige Consumer Healthcare and its competitors.
Is Prestige Consumer Healthcare's Institutional Ownership too high?
Prestige Consumer Healthcare's current Institutional Ownership is 98.30%. Overall, Prestige Consumer Healthcare has a GF Score™ of 68/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Prestige Consumer Healthcare's Institutional Ownership compare to BCRX and AMLX?
Prestige Consumer Healthcare's Institutional Ownership of 98.30% can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Drug Manufacturers company?
A good Institutional Ownership depends on the Drug Manufacturers industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Prestige Consumer Healthcare and its competitors. Prestige Consumer Healthcare's current Institutional Ownership is 98.30%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Prestige Consumer Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Prestige Consumer Healthcare (FRA:PBV) is currently considered Modestly Undervalued. The stock's GF Value™ is €58.90, compared to a current price of €42.20 — trading 28.4% below its estimated fair value. The current Institutional Ownership is 98.30%. Prestige Consumer Healthcare's overall GF Score™ is 68/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For Prestige Consumer Healthcare (FRA:PBV), the current Institutional Ownership is 98.30% as of Aug. 21, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Prestige Consumer Healthcare (FRA:PBV) Overvalued in 2026?

Based on GuruFocus' analysis, Prestige Consumer Healthcare stock appears to be undervalued. The current stock price of €42.20 is trading 28.4% below its estimated GF Value™ of €58.90. GuruFocus considers Prestige Consumer Healthcare to be Modestly Undervalued.

Key valuation signals for FRA:PBV:

  • Institutional Ownership: 98.30%
  • GF Value™: €58.90 vs. price of €42.20 (28.4% below fair value)
  • GF Score™: 68/100 with 2 warning signs

No single metric tells the full story. See the FRA:PBV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Prestige Consumer Healthcare Business Description

Other Exchanges PBH:USA
Address 660 White Plains Road, Tarrytown, NY, USA, 10591
Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige's key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer's Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.
68GF Score

Get the complete analysis for FRA:PBV

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€42.20
Price
€58.90
GF Value